|Mr. Patrick J. Sullivan||Chairman and Chief Exec. Officer||2.03M||19.68k||66|
|Ms. Shacey Petrovic||Pres and Chief Operating Officer||1.28M||N/A||44|
|Mr. Michael L. Levitz||Chief Financial Officer, Sr. VP and Treasurer||826.41k||N/A||44|
|Mr. Bradley A. Thomas||Exec. VP of HR & Organizational Devel.||794.17k||N/A||60|
|Mr. Charles Alpuche||Exec. VP of Global Manufacturing and Operations||915.17k||N/A||58|
Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.
Insulet Corporation’s ISS Governance QualityScore as of January 1, 2018 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 9; Compensation: 5.